Endo Inc.

About Endo Inc.

Endo is a pharmaceutical company dedicated to developing and delivering life-enhancing therapies. Their mission is driven by focused insights and execution, aiming to make a real difference for customers and patients through collaboration and innovation in healthcare solutions.

Products & Services

Specialty Medicines:Empowering patients and building trust with specialists like urologists and orthopedic surgeons to deliver meaningful therapies and seamless experiences for successful outcomes.

Sterile Injectables:Partnering with hospitals and healthcare systems to reduce complexity through life-enhancing solutions, including sterile injectable and ready-to-use products, focusing on value from manufacturing to treatment.

Generics:Delivering high-quality generic products in various forms and dosages through retail, mail-order, and pharmacy networks, achieved through excellence in research, development, manufacturing, and commercialization.

Specialties

Specialty Medical Therapeutics Sterile Injectables High-Value Generic Medicines Urology Care Orthopedic Care Pediatric Endocrinology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Senior Secured Term Loan T: - FT: Senior Secured Term Loan	A: 1500000000 MR: - FA: $1,500.0 million FAN: 1500000000	D: 2024-04-11 FD: 2024-04-11	2 investors
2	RT: Senior Secured Notes T: - FT: Senior Secured Notes	A: 1000000000 MR: - FA: $1,000.0 million FAN: 1000000000	D: 2024-04-11 FD: 2024-04-11	-
3	RT: Senior Secured Notes T: - FT: Senior Secured Notes	A: 1250000000 MR: - FA: $1,250.0 million FAN: 1250000000	D: 2024-04-08 FD: 2024-04-08	-
4	RT: Senior Secured Credit Facilities T: - FT: Senior Secured Credit Facilities	A: 1650000000 MR: - FA: $1,650.0 million FAN: 1650000000	D: 2024-04-01 FD: 2024-04-01	-

Senior Secured Term Loan Latest

2024-04-11

$1.5B

2 investors (Pro only)

Senior Secured Notes 2024-04-11

$1.0B

Senior Secured Notes 2024-04-08

$1.2B

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Mick McGuinness

Senior Vice President, Global Quality and Compliance

T

Tarah Bors

Specialty Sales Executive

J

Julie Davis Sims

Director, Regulatory Affairs

S

Sampathkumar Chittibabu

Vice President, Corporate Affairs, Endo India

R

Rosie Filling

VP & Senior Global Head R&D Operations

View 2 more team members with Pro

Unlock Full Team Directory

Recent News

Endo Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised